Coblopasvir Uses, Dosage, Side Effects and more

Coblopasvir is under investigation in clinical trial NCT03416491 (Safety and Efficacy of KW-136 and Sofosbuvir for Treatment of Chronic Hepatitis C).

Attribute	Details
Trade Name	Coblopasvir
Generic	Coblopasvir
Coblopasvir Other Names	Coblopasvir
Type
Formula	C41H50N8O8
Weight	Average: 782.899 Monoisotopic: 782.375160602
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph